← All companies
MNPR
Monopar Therapeutics Inc.
$111.64
-3.02 -2.63%
Key statistics
from XBRL data in SEC filingsMarket cap
$748M
Revenue (TTM)
$0.00
Net income (TTM)
-$15.0M
EPS (TTM)
$-1.93
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$52.5M
Total assets
$138M
Gross margin
—
52-week range
$29.18 – $116.69
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Regulation FD disclosure
Jul 22, 2026
8-K
Regulation FD disclosure
Jun 30, 2026
8-K
Regulation FD disclosure
Jun 26, 2026
8-K
Shareholder vote results
Jun 23, 2026
8-K
Regulation FD disclosure
May 29, 2026
8-K
Regulation FD disclosure
May 19, 2026
10-Q
Quarter ended 2026-03-31
May 14, 2026
8-K
Results of operations (earnings release)
May 14, 2026
8-K
Regulation FD disclosure
Apr 20, 2026
10-K/A
Fiscal year ended 2025-12-31
Apr 1, 2026
8-K
Results of operations (earnings release)
Mar 27, 2026
10-K
Fiscal year ended 2025-12-31
Mar 27, 2026
8-K
Regulation FD disclosure
Mar 2, 2026
8-K
Results of operations (earnings release)
Nov 13, 2025
10-Q
Quarter ended 2025-09-30
Nov 13, 2025
8-K
Regulation FD disclosure
Nov 10, 2025
8-K
Entered a material agreement; Regulation FD disclosure
Sep 24, 2025
8-K
Regulation FD disclosure
Sep 15, 2025
8-K
Results of operations (earnings release)
Aug 12, 2025
10-Q
Quarter ended 2025-06-30
Aug 12, 2025
8-K
Shareholder vote results
Jun 23, 2025
10-Q
Quarter ended 2025-03-31
May 13, 2025
8-K
Results of operations (earnings release)
May 13, 2025
8-K
Regulation FD disclosure
May 7, 2025
8-K
Results of operations (earnings release)
Mar 31, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K
Director or officer change
Mar 3, 2025
8-K
Director or officer change
Feb 24, 2025
8-K
Entered a material agreement; Unregistered sale of equity
Dec 23, 2024
8-K
Regulation FD disclosure
Dec 6, 2024
8-K
Results of operations (earnings release)
Nov 8, 2024
10-Q
Quarter ended 2024-09-30
Nov 8, 2024
8-K
Entered a material agreement; Regulation FD disclosure
Oct 30, 2024
8-K
Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure; Other events
Oct 24, 2024
8-K
Regulation FD disclosure
Oct 22, 2024
8-K
Regulation FD disclosure
Oct 15, 2024
8-K
Regulation FD disclosure
Oct 7, 2024
8-K
Regulation FD disclosure
Sep 12, 2024
8-K
Regulation FD disclosure
Aug 27, 2024
8-K
Regulation FD disclosure
Aug 21, 2024